HomeCLRB • NASDAQ
add
Cellectar Biosciences Inc
Previous close
$1.58
Day range
$1.52 - $1.61
Year range
$1.39 - $4.45
Market cap
64.10M USD
Avg Volume
405.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.33M | 41.58% |
Net income | -14.66M | -6.79% |
Net profit margin | — | — |
Earnings per share | -0.37 | 55.31% |
EBITDA | -13.26M | -41.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.26M | 80.46% |
Total assets | 37.29M | 73.05% |
Total liabilities | 20.75M | 22.15% |
Total equity | 16.55M | — |
Shares outstanding | 40.57M | — |
Price to book | 39.50 | — |
Return on assets | -99.94% | — |
Return on capital | -212.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -14.66M | -6.79% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1996
Headquarters
Website
Employees
20
